- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.
Look at what they are buying.
Jim Cramer says he's focusing on health-care companies that will break news that moves stocks.